Niclauss Lars, Roulet Liam-Kani, Tozzi Piergiorgio, Dulguerov Filip, Gunga Ziyad, Nowacka Anna, Kirsch Matthias
Cardiovascular Surgery, University Hospital of Lausanne, Lausanne, Switzerland.
Faculty of Medicine, University of Lausanne, Lausanne, Switzerland.
J Int Med Res. 2025 Jan;53(1):3000605241306866. doi: 10.1177/03000605241306866.
The definition of coronary artery bypass graft (CABG)-associated myocardial infarction (MI) is controversial because the postoperative increases in cardiac enzyme activities are multifactorial in origin.
We performed a retrospective case-control study of patients who experienced perioperative MI (cardiac enzyme release, electrocardiographic changes, dysfunction on echocardiography) and those without ischemia to identify risk factors and enzyme activity thresholds.
The estimated incidence of CABG-associated MI was 2.8%. The risk factors were a family history of cardiovascular disease (odds ratio (OR) 2.8), tobacco abuse (OR 3.8), recent MI (OR 3.6), and triple-vessel disease (OR 2.8). The MI group showed higher mortality (OR 2.3), prolonged intubation (OR 3.1), and a prolonged stay in intensive care (OR 4.3). The type 5 MI threshold (10 times the upper limit of the reference range (URL)) was exceeded in 88.4% (troponin I) and 96% (high-sensitivity troponin T; hs-cTnT) of patients without ischemia.
The frequent exceeding of conventional MI-indicating thresholds in patients without ischemia indicates their low specificity. An enzyme activity increase alone is of limited diagnostic value for perioperative MI, which is associated with greater mortality. Finally, the use of a higher threshold for hs-cTnT (>45 × URL) may increase its specificity for graft failure.
冠状动脉旁路移植术(CABG)相关心肌梗死(MI)的定义存在争议,因为术后心脏酶活性升高的原因是多方面的。
我们对经历围手术期心肌梗死(心脏酶释放、心电图改变、超声心动图显示功能障碍)的患者和未发生缺血的患者进行了一项回顾性病例对照研究,以确定危险因素和酶活性阈值。
CABG相关心肌梗死的估计发生率为2.8%。危险因素包括心血管疾病家族史(比值比(OR)2.8)、吸烟(OR 3.8)、近期心肌梗死(OR 3.6)和三支血管病变(OR 2.8)。心肌梗死组的死亡率更高(OR 2.3)、插管时间延长(OR 3.1)和重症监护时间延长(OR 4.3)。在未发生缺血的患者中,88.4%(肌钙蛋白I)和96%(高敏肌钙蛋白T;hs-cTnT)超过了5型心肌梗死阈值(参考范围上限(URL)的10倍)。
未发生缺血的患者频繁超过传统的心肌梗死指示阈值,表明其特异性较低。单独的酶活性升高对围手术期心肌梗死的诊断价值有限,围手术期心肌梗死与更高的死亡率相关。最后,使用更高的hs-cTnT阈值(>45×URL)可能会提高其对移植失败的特异性。